Fulgent Genetics, Inc.(FLGT)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
FLGT has no upcoming report date in the calendar yet. It last reported on Nov 5, 2026; companies usually report every three months.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±13.7%).
Did the stock rise after good news?
The next-day move after each of its last 10 EPS beats and 2 misses.
In plain words: it beat expectations 10 times, but the stock still fell 4 of those 10 times.
- Nov '26Beat▲ +27.2%
- Jul '26Missed▼ -18.1%
- May '26Missed▼ -7.0%
- Feb '26Beat▼ -38.1%
- Nov '25Beat▲ +18.2%
- Aug '25Beat▲ +7.9%
- May '25Beat▲ +19.1%
- Feb '25Beat▼ -1.5%
- Nov '24Beat▼ -11.8%
- Aug '24Beat▲ +6.3%
- May '24Beat▲ +1.2%
- Feb '24Beat▼ -8.1%
Clear beats and misses with a known reaction only. What counts as a beat
Why did FLGT fall after beating earnings?
4 of FLGT's last 12 reactions went against the EPS result. What stands out in each:
FLGT beat EPS estimates in 10 quarters, and the stock still closed lower the next day 4 times. In 2 of the 4 where we have price data, the stock had already run up before the report.
- Feb 27, 2026EPS beat +433.3%stock -38.1% next day
- It had risen 6.4% in the final week before the report, so good news may already have been priced in.
- It opened 23.2% lower as soon as trading resumed.
- Feb 28, 2025EPS beat +110.8%stock -1.5% next day
- It opened 1.7% higher, but sellers took over and it closed -1.5%.
- Nov 8, 2024EPS beat +306.7%stock -11.8% next day
- It had risen 10.2% in the 20 trading sessions before the report, so good news may already have been priced in.
- Feb 28, 2024EPS beat +196.6%stock -8.1% next day
Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was FLGT's earnings move already priced in?
FLGT's move in the month before each of its last 12 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 12 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does FLGT hold its opening gap after earnings?
FLGT's opening move after each report and where it closed that day.
In 10 reports FLGT opened at least 1% away from the previous close. It gave back half or more of that gap by the close 3 of 10 times (30%), and fully reversed 3 times. Gaps up faded 1 of 5; gaps down recovered 2 of 5.
- Nov 5, 2026HeldOpened +9.7%, closed +27.2%
- Jul 30, 2026HeldOpened -14.3%, closed -18.1%
- May 1, 2026HeldOpened -7.6%, closed -7.0%
- Feb 27, 2026HeldOpened -23.2%, closed -38.1%
- Nov 7, 2025HeldOpened +7.8%, closed +18.2%
- Aug 1, 2025HeldOpened +12.0%, closed +7.9%
- May 2, 2025HeldOpened +5.5%, closed +19.1%
- Feb 28, 2025ReversedOpened +1.7%, closed -1.5%
What the history says
- It fell after 4 of its 10 EPS beats (40%): beating estimates has not been enough on its own.
FLGT earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | Revenue surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | After close | -$0.65 | -$0.09 | +86.2% | +2.7% | +27.22% | — |
| Jul 30, 2026 | After close | -$0.44 | -$0.58 | -31.8% | — | -18.11% | -8.21% |
| May 1, 2026 | Before open | -$0.35 | -$0.36 | -2.9% | — | -6.98% | -1.91% |
| Feb 27, 2026 | Before open | $0.03 | $0.16 | +433.3% | — | -38.09% | -44.31% |
| Nov 7, 2025 | Before open | -$0.22 | $0.14 | +163.6% | — | +18.15% | +27.21% |
| Aug 1, 2025 | Before open | -$0.18 | $0.07 | +138.9% | — | +7.86% | +20.95% |
| May 2, 2025 | Before open | -$0.18 | $0.04 | +122.2% | — | +19.07% | +9.10% |
| Feb 28, 2025 | Before open | -$0.37 | $0.04 | +110.8% | — | -1.53% | -1.08% |
| Nov 8, 2024 | Before open | -$0.15 | $0.31 | +306.7% | — | -11.76% | -12.99% |
| Aug 2, 2024 | Before open | -$0.30 | $0.15 | +150.0% | — | +6.32% | +3.01% |
| May 3, 2024 | Before open | -$0.32 | -$0.01 | +96.9% | — | +1.22% | +0.38% |
| Feb 28, 2024 | Before open | -$0.29 | $0.28 | +196.6% | — | -8.14% | -8.79% |
FLGT Earnings FAQ
Answers computed from Fulgent Genetics, Inc.'s reported history
FLGT has no upcoming report date in the calendar yet. It last reported on Nov 5, 2026; companies usually report every three months.
Over the last 12 quarters with a usable EPS surprise, FLGT beat the consensus estimate 10 times (83%), missed 2 and landed in line 0.
Across its last 12 quarters with a measured reaction, FLGT moved an average of ±13.7% in the first session after reporting. It closed higher 50% of the time; the largest gain was 27.2% and the largest drop -38.1%.
FLGT fell in the first session after 4 of its last 10 EPS beats (40%). A beat that was already priced in, or weaker guidance, can send a stock lower. In 2 of the 4 of those falls where price data is available, the stock had already risen before the report.
Across its last 12 quarters with price data, FLGT moved an average of -2.2% in the 20 trading sessions before reporting and was higher in 25% of them. After a drop of 3% or more (5 quarters), it rose the next day 40% of the time, averaging -2.3%. This describes past reports; it is not a forecast.
In 10 reports FLGT opened at least 1% away from the previous close. It gave back half or more of that gap by the close 3 of 10 times (30%), and fully reversed 3 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · FLGT: 12 reported quarters, latest Nov 5, 2026. Information only, not investment advice.
Looking for more on FLGT?
Price charts, forecast, fundamentals and risk pages for FLGT are not on Tickzen yet. You can run a full stock analysis now.
Run the FLGT Stock AnalyzerLatest TickZen Insights
AbbVie (ABBV) Q3 2026 Earnings Preview: Will Skyrizi and Rinvoq be able to justify the 20x?By Vishal Jadaun
Alphabet (GOOG) Q3 2026 Earnings Preview: Will Cloud Overtake Capex?By Vishal Jadaun
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun